Gilead Sciences (GILD) PT Lowered to $89 at Maxim Group
Tweet
Share
E-mail
Get Alerts GILD Hot Sheet
Price: $150.11 -0.52%
Rating Summary:
36 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 9 | New: 26
Rating Summary:
36 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 9 | New: 26
Join SI Premium – FREE
Maxim Group lowered its price target on Gilead Sciences (NASDAQ: GILD) to $89.00 (from $94.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead expands lenacapavir licensing to cover once-yearly HIV prevention
- Takeda Pharmaceutical (4502:JP) (TAK) PT Raised to JPY7,000 at Nomura/Instinet
- Bank of Hangzhou Co Ltd (600926:CH) PT Raised to RMB17.30 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Maxim GroupSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
